The Latest Multiple Sclerosis News – May 17, 2016
We hope you’re having a great week. We've been pretty busy adding exciting new content for you to read, share, and connect to. From our MS Tumblr blog to starting important conversations on Facebook, we're always thinking of ways to empower you. We hope you join us as we create powerful content across multiple platforms.
In the meantime, please enjoy the following MS news stories. You'll notice there are several articles about the gut/brain connection, and we're proud to share with you our very first segment of Empowered By that discusses the topic at length with researcher and professor at the Mt. Sinai School of Medicine, Dr. Patrizia Cassaccia. You can view the broadcast here.
Enjoy reading the wonderful MS news and please leave a comment below with any thoughts you may have.
1. There have been recent advancements in understanding the complex pathogensis of progressive MS (PMS) to develop new treatments. Even though there are no current treatments to slow or stop progressive MS, this is hopeful news!
2. Drug company Roche is testing a new drug that slows the progression of several forms of MS without the side effect of infection that come with other drugs, such as Tecfidera, which may cause PML.
3. Researchers at the Center of Excellence for Myelin Repair are making progress in linking depression in MS patients to gut metabolites with decreased function in myelin forming cells in the brain.
4. A researcher at the Ann Romney Center for Neurologic Disease at BWH is exploring more ways dietary tryptophan acts on the molecular pathways of brain inflammation.
5. An Irish student is traveling to Arizona to compete in the International Science and
Engineering Fair with her invention of a therapy device to improve hand dexterity. Amazing news and something that would please MCPer Mitch Sturgeon, who adjusted his own utensils for an easier eating experience. (Have you done the same? Share your story here!)
6. A drug being developed from an extract of the O. affines plant seems to have potential for the treatment of autoimmune diseases and may be on track for clinical trials in the next two years.
Know of a story we missed? Share it below to let us know.